Fenotypeanalyse viste ingen signifikante ændringer i emtricitabindisposition, medmindre der var udviklet M184V/ I mutation.
Phenotypic analysis showed no significant changes in emtricitabine susceptibility unless the M184V/ I mutation had developed.